BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 322.00
-23.00 (-6.67%)
Aug 26, 2026, 5:29 PM CET
BioArctic AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 105.52 | 1,022 | -177.08 | 229.25 | -11.18 | -119.79 |
Depreciation & Amortization | 15.21 | 15.21 | 13.67 | 7.44 | 14.08 | 13.05 |
Stock-Based Compensation | 24.04 | 24.04 | 19.33 | 16.14 | 2.76 | 1.57 |
Other Operating Activities | 155.35 | 195.27 | -24.35 | 43.72 | -62.21 | -30.22 |
Change in Accounts Receivable | -368.27 | -64.77 | -190.56 | -11.98 | -2.41 | -5.12 |
Change in Other Net Operating Assets | 312.13 | 238.99 | 42.66 | 25.13 | 27.33 | 0.06 |
Operating Cash Flow | 243.98 | 1,431 | -316.33 | 309.69 | -31.64 | -140.46 |
Operating Cash Flow Growth | -76.79% | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -10.24 | -10.24 | -26.64 | -7.44 | -12.75 | -4.39 |
Investment in Securities | -884.4 | -884.4 | 232.27 | -500.04 | -0.02 | -0.03 |
Other Investing Activities | 936.95 | - | 0 | - | 0 | 0 |
Investing Cash Flow | 42.3 | -894.65 | 205.63 | -507.49 | -12.76 | -4.41 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 0.89 | - | - | - | - |
Long-Term Debt Repaid | - | - | -0.33 | -0.92 | -8.79 | -7.39 |
Net Debt Issued (Repaid) | 0.89 | 0.89 | -0.33 | -0.92 | -8.79 | -7.39 |
Issuance of Common Stock | 26.01 | 26.01 | 6.02 | 14.98 | 5.99 | - |
Other Financing Activities | -180.58 | - | -0 | -0 | - | - |
Financing Cash Flow | -153.68 | 26.9 | 5.69 | 14.06 | -2.81 | -7.39 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.59 | -35.82 | 6.37 | -10.09 | 4.19 | 0.72 |
Miscellaneous Cash Flow Adjustments | 0 | - | -0 | - | -0 | - |
Net Cash Flow | 133.2 | 527.5 | -98.64 | -193.82 | -43.02 | -151.54 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 233.73 | 1,421 | -342.97 | 302.25 | -44.38 | -144.84 |
Free Cash Flow Growth | -77.19% | - | - | - | - | - |
Free Cash Flow Margin | 23.32% | 71.07% | -133.27% | 49.07% | -19.35% | -564.40% |
Free Cash Flow Per Share | 2.63 | 16.01 | -3.87 | 3.42 | -0.50 | -1.65 |
Levered Free Cash Flow | 215.84 | 1,161 | -287.35 | 210.92 | -34.44 | -91.07 |
Unlevered Free Cash Flow | 215.84 | 1,162 | -287.35 | 211.13 | -34.09 | -90.55 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 2.35 | 2.35 | 1.85 | 0.38 | 0.75 | 0.98 |
Cash Income Tax Paid | 71.6 | 71.6 | 0.52 | -0.16 | -0.34 | 0.31 |
Change in Working Capital | -56.15 | 174.22 | -147.91 | 13.15 | 24.91 | -5.06 |